Further evidence corroborating a tumor-suppressive role of DAPK2 comes from hematological malignancies, where its stable over-expression enhances all-trans retinoic acid (ATRA)-induced granulocytic differentiation of leukemic cell lines [12]. This evidence concerns the gene DAPK2 and neoplasm.